Previous studies have reported increased activation of NF‐κB with increased production of proinflammatory cytokines in T1DM condition and suppression of prediabetic cytokine production by a NF‐κB inhibitor (Shao et al., 2015; Triñanes et al., 2012). The gene discussed is NFKB1; the disease is type 1 diabetes mellitus.